FCER1A genetic variability and serum IgE levels
D. Potaczek,K. Okumura,C. Nishiyama
DOI: https://doi.org/10.1111/j.1398-9995.2009.02090.x
2009-09-01
Abstract:We read with keen interest a very recent study by Chen et al. (1), which further expands on the recent findings byWeidinger et al. (2) who reported on the results of large genome-wide scan that demonstrated IgE receptor (FceRI) a-chain (Fc RIa) gene (FCER1A) variability to be a major marker of serum IgE levels in population. Chen et al. (1) successfully showed an association between FCER1A variants and serum IgE levels present in cord blood/small children to be independent of environmental stimuli, which seems to be an important genetic input on our understanding of multi-factorial etiology of allergic disorders.We would like to congratulate the authors of both the above very analytically powerful studies (1, 2) for scientific and statistical power as well as for elegance and excellence of their work. The large and powerful trials by Weidinger et al. (2) and Chen et al. (1) demonstrated two common variants FCER1A rs2427837 and rs2251746 to be strongly associated with serum IgE levels in general and paediatric populations. While direct evidence for strong functional activity of rs2251746 FCER1A proximal promoter polymorphism was previously demonstrated (3, 4), showing it to be a potent regulator of FCER1A/FceRIa expression in mast cells and/or basophils, no such data were yet provided for rs2427837 variant. Therefore, an association between rs2427837 polymorphism and IgE levels (1, 2) might possibly result from its almost complete linkage disequilibrium (1, 2) with functional (3, 4) rs2251746 variant. One might also cautiously speculate that some more functional FCER1A variants could by their haplotypic relationships/interplay with rs2251746 polymorphism, at least in small part, functionally contribute to the association with serum IgE levels observed for rs2251746 variant in population (1, 2). For example, rs2427827 polymorphism, close neighbour of rs2251746 variant in FCER1A proximal promoter, was also demonstrated to affect FCER1A transcriptional activity/FceRIa expression in mast cells and/or basophils (4, 5) in an additive manner with rs2251746 polymorphism (4). While the regulatory mechanism by which (serum) IgE upregulates cell surface Fc RI expression is well known (6), no direct evidence for the causal role of FceRI(a), FCER1A or FCER1A genetic variants in regulation of IgE synthesis and/ or levels was yet provided. Therefore, it might be only speculated that any alterations in FceRI expression, including also those genotype-related, might affect IgE synthesis and/or levels. Thus, previous results showing how FCER1A proximal promoter polymorphisms regulate FceRI(a) expression in mast cells and/or basophils (3–5) might provide only a partial mechanistic background for previously observed FCER1A genetic variants-serum IgE levels genotype-phenotype associations (1, 2, 5). Further functional studies focused on the analysis evaluating the putative effects of (genotype-related) alterations in FceRI expression level on IgE production/ levels seem to be required to reveal the underlying mechanism(s).